Survey Results -

Life Sciences and Tech IPOs Continued Hot Streak in Second Half -

The life sciences and technology IPO markets continued their strong performance in the second half of 2018, notwithstanding significant market volatility, a sharp decline in the stock market and a looming federal government shutdown at the end of the year.

The year started slowly but then quickly gained steam with an unusual number of IPOs over the summer before activity slowed again in the last few months.

By the Numbers -

The 57 life sciences and technology offerings completed in the second half of 2018 were on par with the 56 in the first half of the year and made for the highest number for a half-year period since the first half of 2015, when 55 such offerings were completed.